首页 正文

Current status of GPR40/FFAR1 modulators in medicinal chemistry (2016-2019): a patent review

{{output}}
Introduction: The activation of free fatty acid receptor 1 (FFAR1) induces insulin secretion in a glucose-dependent manner, and thereby is considered as an attractive anti-diabetic target. The clinical studies provided a lot of evidence that FFAR1 agonists imp... ...